Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 2/2017

21.11.2016 | Original Article

University Hospital Waterford: 5-year experience of cutaneous melanoma

verfasst von: R. Sehgal, C. X. Cheung, R. Alradadi, D. A. Healy, R. Landers, G. T. O’Donoghue

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The incidence of cutaneous melanoma (CM) continues to rise in Ireland. Despite significant advances in melanoma molecular therapy, surgery remains the mainstay of treatment for CM. The University Hospital Waterford (UHW) prospectively maintained CM registry was established in 2010.

Aim

To summarize 5-year experience (2010–2015) of primary CM presenting to UHW.

Methods

Data were retrospectively obtained from a central electronic pathology and radiology repository augmented by HIPE data and theatre logs. Data collected included patient demographics and clinico-pathological characteristics, specimen number, size, anatomical location, melanoma subtype, Breslow thickness, Clark’s level, ulceration, and mitosis.

Results

592 CMs were managed in UHW during the study period. Overall, females comprised the majority of cases with mean age at presentation 60.78 ± 18.29 years. The most commonly affected anatomical location was the lower limb (26.7%) followed by the back (15.1%), upper limb (15.07%), and face (14.40%). Superficial spreading and lentigo maligna were the most common histological subtype accounting for 19.8 and 20%, respectively. Overall, the mean Breslow depth was 2.4 ± 3.7 mm with corresponding Clark’s Level III. Sentinel lymph node positivity was 39/103 (37.89%) most commonly located in the axilla (53.8%) and groin (30.7%).

Conclusion

There has been a steady increase in the number of cutaneous melanoma presentations over the past 5-years to the South East Cancer Centre. Patients are managed best by prompt surgical excision and multidisciplinary management. Our results are in keeping with international standards and work continues in determining overall 5-year survival and recurrence rates.
Literatur
1.
Zurück zum Zitat Erdmann F, Lortet-Tieulent J, Schüz J, Zeeb H, Greinert R, Breitbart EW et al (2013) International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higheror lower risk? Int J Cancer 132(2):385–400CrossRefPubMed Erdmann F, Lortet-Tieulent J, Schüz J, Zeeb H, Greinert R, Breitbart EW et al (2013) International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higheror lower risk? Int J Cancer 132(2):385–400CrossRefPubMed
2.
Zurück zum Zitat Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Rosso S, Forman D et al (2015) The European Cancer Observatory: a new data resource. Eur J Cancer 51(9):1131–1143CrossRefPubMed Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Rosso S, Forman D et al (2015) The European Cancer Observatory: a new data resource. Eur J Cancer 51(9):1131–1143CrossRefPubMed
3.
Zurück zum Zitat Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E et al (2015) Survival of patients with skin melanoma in Europe increases further: Results of theEUROCARE-5 study. Eur J Cancer 51(15):2179–2190CrossRef Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E et al (2015) Survival of patients with skin melanoma in Europe increases further: Results of theEUROCARE-5 study. Eur J Cancer 51(15):2179–2190CrossRef
5.
Zurück zum Zitat Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P et al (2005) Meta-analysis of risk factors for cutaneous melanoma: i. Common and atypical naevi. Eur J Cancer 41(1):28–44CrossRefPubMed Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P et al (2005) Meta-analysis of risk factors for cutaneous melanoma: i. Common and atypical naevi. Eur J Cancer 41(1):28–44CrossRefPubMed
6.
Zurück zum Zitat Hollestein LM, van den Akker SA, Nijsten T, Karim-Kos HE, Coebergh JW, de Vries E (2012) Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. Ann Oncol 23(2):524–530CrossRefPubMed Hollestein LM, van den Akker SA, Nijsten T, Karim-Kos HE, Coebergh JW, de Vries E (2012) Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. Ann Oncol 23(2):524–530CrossRefPubMed
7.
Zurück zum Zitat Geilen CC, Georgieva J, Milling A, Farthmann B (2006) Malignant melanoma–markers for progression and prognosis in malignant melanoma. Front Radiat Ther Oncol 39:120–126PubMed Geilen CC, Georgieva J, Milling A, Farthmann B (2006) Malignant melanoma–markers for progression and prognosis in malignant melanoma. Front Radiat Ther Oncol 39:120–126PubMed
8.
Zurück zum Zitat Hunter HL, Dolan OM, McMullen E, Donnelly D, Gavin A (2013) Incidence and survival in patients with cutaneous malignant melanoma: experience in a U.K. population 1984–2009. Br J Dermatol 168(3):676–678CrossRefPubMed Hunter HL, Dolan OM, McMullen E, Donnelly D, Gavin A (2013) Incidence and survival in patients with cutaneous malignant melanoma: experience in a U.K. population 1984–2009. Br J Dermatol 168(3):676–678CrossRefPubMed
9.
Zurück zum Zitat Ortega Candil A, Rodríguez Rey C, Carreras Delgado JL (2012) Malignant melanoma. SRN Dermatol 2012:308279 Ortega Candil A, Rodríguez Rey C, Carreras Delgado JL (2012) Malignant melanoma. SRN Dermatol 2012:308279
10.
Zurück zum Zitat Yee VS, Thompson JF, McKinnon JG, Scolyer RA, Li LX, McCarthy WH et al (2005) Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 12(6):429–439CrossRefPubMed Yee VS, Thompson JF, McKinnon JG, Scolyer RA, Li LX, McCarthy WH et al (2005) Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 12(6):429–439CrossRefPubMed
11.
Zurück zum Zitat Thompson JF, Scolyer RA, Uren RF (2006) Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am 15(2):301–318CrossRefPubMed Thompson JF, Scolyer RA, Uren RF (2006) Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am 15(2):301–318CrossRefPubMed
12.
Zurück zum Zitat Pringle JH (1908) A method of operation in cases of melanotic tumours of the skin. Edin Med J. 23:496–497 Pringle JH (1908) A method of operation in cases of melanotic tumours of the skin. Edin Med J. 23:496–497
13.
Zurück zum Zitat Hogarth Pringle J (1937) Cutaneous melanoma two cases alive thirty and thirty-eight years after operation. Lancet 229(5922):508–509CrossRef Hogarth Pringle J (1937) Cutaneous melanoma two cases alive thirty and thirty-eight years after operation. Lancet 229(5922):508–509CrossRef
14.
Zurück zum Zitat Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355(13):1307–1317CrossRefPubMed Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355(13):1307–1317CrossRefPubMed
15.
Zurück zum Zitat Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF et al (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370(7):599–609CrossRefPubMedPubMedCentral Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF et al (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370(7):599–609CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Boland MR, Prichard RS, Bass GA, Al-Hilli Z, Levendale A, Gibbons D et al (2015) Malignant melanoma: factors affecting the surgical interval from excision biopsy to definitive surgical management. Ir J Med Sci 184(2):511–515CrossRefPubMed Boland MR, Prichard RS, Bass GA, Al-Hilli Z, Levendale A, Gibbons D et al (2015) Malignant melanoma: factors affecting the surgical interval from excision biopsy to definitive surgical management. Ir J Med Sci 184(2):511–515CrossRefPubMed
18.
Zurück zum Zitat Boniol M, Autier P, Boyle P, Gandini S (2012) Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 345:4757CrossRef Boniol M, Autier P, Boyle P, Gandini S (2012) Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 345:4757CrossRef
21.
Zurück zum Zitat Situm M, Buljan M, Kolić M, Vučić M (2014) Melanoma–clinical, dermatoscopical, and histopathological morphological characteristics. Acta Dermatovenerol Croat. 22(1):1–12PubMed Situm M, Buljan M, Kolić M, Vučić M (2014) Melanoma–clinical, dermatoscopical, and histopathological morphological characteristics. Acta Dermatovenerol Croat. 22(1):1–12PubMed
22.
Zurück zum Zitat Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD (2005) Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990–2000. J Invest Dermatol. 125(4):685–691CrossRefPubMed Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD (2005) Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990–2000. J Invest Dermatol. 125(4):685–691CrossRefPubMed
23.
Zurück zum Zitat Kvaskoff M, Siskind V, Green AC (2012) Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia. Arch Dermatol 148(2):164–170CrossRefPubMed Kvaskoff M, Siskind V, Green AC (2012) Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia. Arch Dermatol 148(2):164–170CrossRefPubMed
24.
Zurück zum Zitat Farma JM, Kulkarni N, Hsu C (2015) Surgical management of primary and recurrent melanoma. Surg Oncol Clin N Am 24(2):239–247CrossRefPubMed Farma JM, Kulkarni N, Hsu C (2015) Surgical management of primary and recurrent melanoma. Surg Oncol Clin N Am 24(2):239–247CrossRefPubMed
25.
Zurück zum Zitat Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U, Cervantes A et al (2015) Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):126–132CrossRef Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U, Cervantes A et al (2015) Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):126–132CrossRef
26.
Zurück zum Zitat Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH et al (2010) Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 163(2):238–256CrossRefPubMed Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH et al (2010) Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 163(2):238–256CrossRefPubMed
27.
Zurück zum Zitat Melanoma: Assessment and Management (2015) National Collaborating Centre for Cancer (UK). London: National Institute for Health and Care Excellence (UK) Melanoma: Assessment and Management (2015) National Collaborating Centre for Cancer (UK). London: National Institute for Health and Care Excellence (UK)
Metadaten
Titel
University Hospital Waterford: 5-year experience of cutaneous melanoma
verfasst von
R. Sehgal
C. X. Cheung
R. Alradadi
D. A. Healy
R. Landers
G. T. O’Donoghue
Publikationsdatum
21.11.2016
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 2/2017
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-016-1531-6

Weitere Artikel der Ausgabe 2/2017

Irish Journal of Medical Science (1971 -) 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.